VANCOUVER, British Columbia, August 1, 2018 /PRNewswire/ --
MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC:MYMMF) ("MYM") is pleased to announce it has entered into a two-year agreement with Amsterdam-based Dutch Passion for the production and distribution of Dutch Passion branded products and seed genetics in Australia.
"We are thrilled to be working with Dutch Passion in Australia. With over 30 years-experience in the development and distribution of cannabis seeds, they are considered to be world leaders," said Rob Gietl, CEO of MYM. "As legal production of cannabis has been rapidly increasing worldwide, so has the demand for seed genetics. The Dutch Passion portfolio of seeds will prove to be a very valuable asset to the shareholders of MYM."
Eric Siereveld, CEO of Dutch Passion Seed Company commented, "There were a lot of options when we were considering working with producers in Australia. We chose to partner with MYM because of their strong network and organization in the global cannabis industry. We are confident that MYM has the best environment to maximize the potential of the genetic products we offer."
Dutch Passion agreed to give MYM exclusive rights in Australia to produce and distribute under the Dutch Passion brand, all products that Dutch Passion sells currently and may sell in the future, including: clones, flowers, pre-rolled joints and other cannabis products. Australia is poised to be one of the worlds leading exporters of Cannabis products due to its favorable growing environment and low production costs. Dutch Passion also agreed to give MYM non-exclusive rights in Australia to produce and/or distribute cannabis seeds under the Dutch Passion brand.
MYM agreed to make Dutch Passion its flagship brand of cannabis seeds for sale in Australia and Dutch Passion agreed to list MYM as an official distributor of products in Australia.
About Dutch Passion
Dutch Passion is a Dutch company with over 30 years' experience in the development and distribution of cannabis seeds. Dutch Passion is focused on producing high quality, high-THC cannabis genetics and on providing attentive customer service through its experienced customer service team. Dutch Passion's diverse seed collection of international cannabis genetics dates back to the 1970s, with all varieties having passed strict tests designed to ensure ease of growth, heavy yields and high-quality results. In the 1990s, Dutch Passion invented feminized cannabis seeds and, more recently, helped to pioneer the success of high-THC auto-flowering cannabis seeds. http://www.dutch-passion.com
About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that when completed are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in two international cannabis production projects in Australia and Colombia. In New South Wales, Australia, the "Northern Rivers Project" is expected to have 1.2 million square feet of cannabis production space. In Medellin, Colombia, MYM and Colombia Organica have partnered and are planning to build a cannabis production facility in the region. Colombia Organica currently holds a seed to sale license for low THC cannabis which permits the company to grow, produce and create cannabis derivatives to be commercialized and / or exported. Colombia Organica is in the licensing process for the cultivation and production of high THC cannabis extracts. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA: 0MY) (DEU: 0MY) (MUN: 0MY) (STU: 0MY).
This release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws, including statements regarding the production and distribution of Dutch Passion branded products in Australia, the anticipated access to and commercial value of Dutch Passion's list of seeds and cannabis products, the anticipated combined production space of 1.5 million square feet for the two production projects in Quebec, the anticipated 1.2 million square feet of production space in the Northern Rivers Project, and the building of a cannabis production facility in Colombia. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends," "anticipates," "it is expected," or variations of such words and phrases, or statements that certain actions, events or results "may," "could," "should," or "would" occur. Forward-looking statements are based on certain material assumptions and analyses made by the Company and the opinions and estimates of management as of the date of this press release, including the assumption that the terms and conditions of the agreements with Dutch Passion will be carried out and satisfied as anticipated, that MYM will have access to Dutch Passion's list of seeds and cannabis products and that it will be a commercially valuable asset, that the Northern Rivers Project will be completed as planned, including the construction and operation of 1.2 million square feet of production space, that MYM's projects in Quebec will be completed as planned, with 1.5 million square feet of greenhouse space, and that the cannabis production facility will be successfully built near Medellin, Colombia as anticipated by MYM. Although the Company considers these assumptions to be reasonable based on information currently available to it, they may prove to be incorrect, and the forward-looking statements in this release are subject to numerous risks, uncertainties and other factors that may cause future results to differ materially from those expressed or implied in such forward-looking statements. Such risk factors may include, among others, the risk that the terms and conditions of the agreements with Dutch Passion will not be carried out or satisfied as anticipated, or at all, that MYM will not have access to Dutch Passion's list of seeds and cannabis products due to unforeseen complications or, if it does, that such list of seeds and cannabis products will not be commercially valuable, MYM's Quebec projects will not be successfully built as planned, the Northern Rivers Project will not be successfully built as planned, the cannabis production facility will not be successfully built as planned, and the other risks and uncertainties applicable to the Company's business as set forth in the Company's management discussion and analysis and annual information form and the Company's other disclosure available under the Company's profile at http://www.sedar.com. There can be no assurance that the transactions contemplated in this news release will complete. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that is incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
Contacts: Investor Relations Terry Brown +1-855-696-2261 firstname.lastname@example.org
SOURCE MYM Nutraceuticals Inc.
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All